Mateo Marin-Cuartas

Video

Updated 5-Year TAVR vs SAVR Outcomes in Low-Risk Patients: An Interview With Drs. Marin-Cuartas and Heuts

March 5, 2026 | Mateo Marin-CuartasGold Contributor…

In this outstanding interview, CTSNet Editor-in-Chief Joel Dunning speaks with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart Centre University Hospital in Leipzig, SN,...

Podcast

The Beat With Joel Dunning Ep. 158: JACC: Case Reports

May 28, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Gilbert Tang, Editor-in-Chief of Journal of the American College of Cardiology (JACC): Case Reports, professor in the Department...

Video

The Effects of Mitral Surgery on Ventricular Arrhythmias in Patients With Arrhythmic Mitral Valve Prolapse: An Interview With Dr. Michael Borger

May 22, 2026 | Mateo Marin-CuartasGold Contributor…

At the 2026 American Association for Thoracic Surgery (AATS) Annual Meeting, CTSNet JANS Editor Dr. Mateo Marin-Cuartas, a cardiac surgeon at Leipzig Heart Center, Germany, spoke with Dr. Michael Borger,...

Video

Updated 5-Year TAVR vs SAVR Outcomes in Low-Risk Patients: An Interview With Drs. Marin-Cuartas and Heuts

March 5, 2026 | Mateo Marin-CuartasGold Contributor…

In this outstanding interview, CTSNet Editor-in-Chief Joel Dunning speaks with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart Centre...

Podcast

The Beat With Joel Dunning Ep. 147: Updated 5-Year TAVR vs SAVR Outcomes in Low-Risk Patients

March 5, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart...

JANS Article

Cutibacterium Acnes Infective Endocarditis—An Emerging Pathogen

December 27, 2024 | Mateo Marin-CuartasGold Contributor

In this multicenter study, the authors aimed to review patients undergoing surgical intervention for infective endocarditis caused by Cutibacterium acnes and analyze the diagnostic challenges and operative results. A total...

JANS Article

External Validation of EuroSCORE I and II in Patients With Infective Endocarditis: Results From a Nationwide Prospective Registry

December 19, 2024 | Mateo Marin-CuartasGold Contributor

In this study, the authors aimed to externally validate EuroSCORE I and II in patients surgically treated for infective endocarditis. Furthermore, the authors assessed the predictive performance of both models...

JANS Article

Quality of Life After Transcatheter Tricuspid Valve Replacement: One-Year Results From TRISCEND II Pivotal Trial

December 12, 2024 | Mateo Marin-CuartasGold Contributor

In this study, the authors conducted an in-depth analysis of the health status of patients enrolled in the TRISCEND II pivotal trial (Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical...

JANS Article

Transcatheter Valve Replacement in Severe Tricuspid Regurgitation

December 12, 2024 | Mateo Marin-CuartasGold Contributor

In the TRISCEND II trial, a total of 400 patients with severe symptomatic tricuspid regurgitation were randomized in a 2:1 ratio to undergo either transcatheter tricuspid valve replacement with medical...

JANS Article

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED trial

December 5, 2024 | Mateo Marin-CuartasGold Contributor

Development of myocardial fibrosis in patients with aortic stenosis precedes left ventricular decompensation and is associated with an adverse long-term prognosis. This study aimed to investigate whether early valve intervention...

JANS Article

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD

November 26, 2024 | Mateo Marin-CuartasGold Contributor

Neurohormonal modulation and afterload reduction are essential for treating heart failure with reduced ejection fraction (HFrEF). In HFrEF patients with concomitant moderate aortic stenosis (AS), therapy with transcatheter aortic valve...

JANS Article

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis—EARLY TAVR Trial

November 26, 2024 | Mateo Marin-CuartasGold Contributor

The EARLY TAVR trial investigators randomly assigned patients with asymptomatic severe aortic stenosis to undergo either early transfemoral transcatheter aortic valve replacement (TAVR) or clinical surveillance. The primary end point...

JANS Article

Clinical Outcomes of Mitral Valve Surgery in Atrial Functional Mitral Regurgitation in the REVEAL-AFMR Registry

November 21, 2024 | Mateo Marin-CuartasGold Contributor

This cohort study, called the Real-World Observational Study for Investigating the Prevalence and Therapeutic Options for Atrial Functional Mitral Regurgitation (REVEAL-AFMR), aimed to investigate the prevalence, clinical characteristics, and outcomes...

LOAD MORE
ADVERTISE ON CTSNET